Please enable Javascript
Conferences
Partners
Expert Interviews
Subscribe
Breast Cancers Today
HER2 Breast Cancer
HR Breast Cancer
Triple-Negative Breast Cancer
Genetics & Breast Cancer
Gastro Today
Inflammatory Bowel Disease
Irritable Bowel Syndrome
Hepatitis
Heme Today
Anemia
Deep Vein Thrombosis
Essential Thrombocythemia
Hemophilia
Immune Thrombocytopenic Purpura
Myelodysplastic Syndromes
Myelofibrosis
Myeloproliferative Neoplasms
PNH
Polycythemia Vera
Pulmonary Embolism
Sickle Cell Disease
Thrombocytopenia
Thrombophilia
Thrombosis
Thrombotic Thrombocytopenic Purpura
Venous Thromboembolism
von Willebrand Disease
Metabolic Care Today
Diabetes
Obesity
Nephrology Times
Acute Kidney Injury
ADPKD
Anemia and Kidney Disease
Chronic Kidney Disease
COVID-19 and Kidney Disease
Diabetes and Hypertension
End-Stage Renal Disease
Gout
Hyperkalemia
IgAN
Kidney Transplantation
Metabolic Acidosis
Sleep
More
Career News
Future of Medicine
Health and Wellness
— HIV
Infectious Diseases
Lupus
Neurology
Oncology
Ophthalmology
— Demodex Blepharitis
Orthopedics
Pharmacology
Pulmonology
Rheumatology
Urology
Lauren Dembeck, PhD
Lauren Dembeck, PhD
Lauren Dembeck, PhD, is a freelance science & medical writer.
Articles by Lauren Dembeck, PhD
HER2DX Adds Prognostic Precision in Early HER2+ Breast Cancer
Lauren Dembeck, PhD
Genetics & Breast Cancer
|
July 16, 2025
HER2DX predicts outcomes in early HER2+ breast cancer, adding prognostic value beyond standard clinical-pathologic factors.
Read More
Amycretin Trial Shows Promising Weight Loss Results
Lauren Dembeck, PhD
Obesity
|
July 16, 2025
Amycretin shows significant weight loss and tolerability in early trial, supporting further study for obesity treatment.
Read More
Novel Risk Prediction Model for Gastroesophageal Reflux Disease
Lauren Dembeck, PhD
Gastroenterology
|
July 15, 2025
A new lifestyle-based GERD Risk Scoring System shows high accuracy in identifying at-risk individuals for early intervention.
Read More
Mesenchymal Stem Cell–Derived Vesicles Reduce IBS Burden
Lauren Dembeck, PhD
IBS
|
July 14, 2025
New research shows stem cell-derived apoptotic vesicles may ease IBS by restoring brain-gut balance via the 5-HT pathway.
Read More
AI Decodes Herbal Remedies for Cough-Variant Asthma
Lauren Dembeck, PhD
Asthma
|
July 14, 2025
AI and graph models reveal how Suhuang herbs target lung tissues, blending TCM theory with molecular science.
Read More
Strategies for Managing Colorectal Polyps and Cancer Risk
Lauren Dembeck, PhD
Colon Polyps
|
July 14, 2025
Rising colorectal cancer rates in young adults highlight the urgent need for precise screening and polyp management.
Read More
Two Decades of IBS Tweets Offer Insight Into Patient Experience and Care Priorities
Lauren Dembeck, PhD
IBS
|
July 14, 2025
Social media offers key insights into IBS lived experiences, highlighting patient needs, support, and care gaps.
Read More
Ensifentrine Is a Novel Option for Maintenance Treatment of COPD
Lauren Dembeck, PhD
Pulmonology
|
July 10, 2025
Ensifentrine offers a novel, inhaled option to improve COPD symptoms in patients not controlled on dual bronchodilators.
Read More
Gene Model Predicts Risk in Head and Neck Cancer
Lauren Dembeck, PhD
Head and Neck Cancer
|
July 8, 2025
Researchers identified 4 genes tied to propionate metabolism to predict head and neck cancer risk and survival.
Read More
Nutritional Epigenetics Intervention Proposed to Prevent Autism, ADHD in Children
Lauren Dembeck, PhD
Neurodivergent
|
July 8, 2025
Nutritional epigenetics may help prevent autism and ADHD via maternal diet changes.
Read More
Multi-Strain Probiotic Well Tolerated by Patients With IBD and IBS Symptoms
Lauren Dembeck, PhD
IBD
|
July 3, 2025
A four-strain probiotic is safe and shows symptom relief trend in patients with IBD/IBS overlap, study shows.
Read More
Comorbidities and Systemic Steroid Use Drive Pneumonia Risk in Patients With IBD
Lauren Dembeck, PhD
IBD
|
July 3, 2025
Steroids and comorbidities—not IBD itself—drive pneumonia risk in IBD, study finds.
Read More
FDA Authorizes First AI Platform for Breast Cancer Risk Prediction
Lauren Dembeck, PhD
Breast Cancer News
|
June 27, 2025
FDA authorizes CLAIRITY BREAST, the first AI tool to predict 5-year breast cancer risk from screening mammograms.
Read More
EGFR Inhibitors May Help Patients With Treatment-Resistant NF1-Mutant Melanoma
Lauren Dembeck, PhD
Melanoma
|
June 27, 2025
NF1-mutant melanoma may respond to EGFR inhibitors, offering hope for patients resistant to immunotherapy.
Read More
Digital Inhaler Metrics May Predict Impending Acute COPD Exacerbations
Lauren Dembeck, PhD
Pulmonology
|
June 26, 2025
Digital inhaler data may predict COPD exacerbations up to 14 days early, offering a potential remote monitoring tool.
Read More
Long-Term Drop in Type 2 Diabetes With Lifestyle and Metformin Interventions in DPP
Lauren Dembeck, PhD
Type 2 Diabetes
|
June 25, 2025
Lifestyle and metformin interventions cut diabetes risk for 21 years in adults with prediabetes, DPP study shows.
Read More
Black Youth With Dysglycemia Exhibit Low Metabolic Clearance Rate of Insulin
Lauren Dembeck, PhD
Obesity
|
June 24, 2025
Black youth with dysglycemia show reduced insulin clearance, possibly contributing to β-cell dysfunction and ...
Read More
Weight Reduction Following Obesity Treatment Varies by Timing of Treatment Discontinuation
Lauren Dembeck, PhD
Obesity
|
June 19, 2025
Real-world weight loss with semaglutide or tirzepatide is lower due to early discontinuation and low maintenance dosing.
Read More
ASCENT-04/KEYNOTE-D19 Supports Sacituzumab Govitecan Plus Pembrolizumab As New Standard of Care in Advanced PD-L1–Positive TNBC
Lauren Dembeck, PhD
Triple-Negative Breast Cancer
|
June 4, 2025
Sacituzumab + pembrolizumab improves PFS vs chemo in PD-L1+ TNBC, per ASCENT-04/KEYNOTE-D19 phase 3 trial at ASCO 2025.
Read More
Elinzanetant Eases Vasomotor Symptoms in HR+ Breast Cancer
Lauren Dembeck, PhD
HR Breast Cancer
|
June 3, 2025
Elinzanetant reduces vasomotor symptoms from endocrine therapy in HR+ breast cancer, with rapid onset and good tolerability.
Read More
Load More